Community-Based Ototoxicity Monitoring for Drug-Resistant Tuberculosis in South Africa: An Evaluation Study [PDF]
In response to the drug-resistant tuberculosis (DRTB) ototoxicity burden in South Africa, ototoxicity monitoring has been decentralised, with community health workers (CHWs) acting as facilitators.
De Wet Swanepoel +2 more
exaly +4 more sources
Survivors’ Perspectives on Cisplatin-Induced Ototoxicity and Barriers to Ototoxicity Monitoring [PDF]
Cisplatin-based chemoradiation therapy (CRT) causes ototoxicity in survivors of head and neck (H&N) cancer, but rates of audiologic follow-up are poor. Our objective is to identify (1) QOL domains that are affected by treatment-related ototoxicity and (2) barriers to ototoxicity monitoring among survivors of H&N cancer to inform patient-centered ...
David S Lee +2 more
exaly +4 more sources
Cisplatin-induced ototoxicity: the current state of ototoxicity monitoring in New Zealand. [PDF]
Background: Many well-known pharmacologic agents have been shown to have toxic effects to the cochleo-vestibular system. Examples of such ototoxic agents include cisplatin and aminoglycoside antibiotics. Ototoxicity monitoring consists of a comprehensive pattern of audiological assessments designed to detect the onset of any hearing loss.
Venter, Kinau
openaire +3 more sources
Ototoxicity Associated with Antineoplastic Agents in the Pediatric Population: An Evidence-Based Review of Auditory Monitoring Strategies and Contemporary Diagnostic Frameworks—Narrative Review [PDF]
Ototoxicity represents a clinically significant complication of anticancer therapy in pediatric patients. Cytotoxic agents used in oncology, particularly platinum-based chemotherapy, may induce damage to the auditory and vestibular systems, resulting in ...
Aleksandra Wojno +4 more
doaj +2 more sources
Mechanisms, prevention, and management of aminoglycoside-induced hearing loss in neonates and children: a translational review [PDF]
ObjectiveAminoglycoside antibiotics remain essential for treating serious neonatal and pediatric infections, yet carry a well-documented risk of permanent auditory and vestibular toxicity.
Sílvia M. Illamola +11 more
doaj +2 more sources
Monitoring Ototoxicity with DPOAEs [PDF]
Ototoxicity is damage to the ears following exposure to medications. It is a common yet a preventable cause of hearing and/or balance problems. There are hundreds of drugs and chemicals that can cause hearing loss with the most established ototoxic drugs
Al-Malky, GMA
openaire +2 more sources
Cisplatin-Associated Ototoxicity: A Review for the Health Professional [PDF]
Cisplatin is an effective drug used in the treatment of many cancers, yet its ototoxic potential places cancer patients, exposed to this drug, at risk of hearing loss, thus negatively impacting further on a patient’s quality of life.
Jessica Paken +3 more
doaj +2 more sources
Monitoring Ototoxicity in Cancer Patients Undergoing Platinum-Based Chemotherapy and Radiation in Saudi Arabia: Challenges and Solutions [PDF]
Arwa AlJasser Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Arwa AlJasser, Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud ...
AlJasser A
doaj +2 more sources
Platinum-based compounds used for treating hematologic malignancies can lead to various side effects. One such side effect is ototoxicity, which is characterized by permanent bilateral sensorineural hearing loss or tinnitus.
Aleksandra Janowiak-Majeranowska +3 more
doaj +2 more sources
An overview of pharmacotherapy-induced ototoxicity [PDF]
This article provides an overview of ototoxic medication, as well as different pharmacological and audiological monitoring strategies. Although ototoxic medications play an important role in modern medicine, they also have the capacity to do great harm ...
Natalie Schellack, Alida Naude
doaj +2 more sources

